Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Study product A (Wonderlab wonder4shape)
Chongqing Precision Biotech Co., Ltd
Overweight
1 trial -
Study product A (Wonderlab wonder4shape)
Chongqing Precision Biotech Co., Ltd
Overweight and Obesity
1 trial -
Tadalafil 2.5Mg Tab
Hospital Authority, Hong Kong
Erectile Dysfunction
1 trial -
Tafolecimab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Coronary Syndrome
1 trial -
Tests of the expression of CXCL3 in various tissues
The First People's Hospital of Lianyungang
Diabetic Kidney Disease (DKD)
1 trial -
Tislelizumab combined with Lenvatinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Initially Unresectable Hepatocellular Carcinoma
1 trial -
Treatment
United Therapeutics Europe Ltd
Glucose Metabolism Disorders
1 trial -
UMULINE NPH
Takeda
Type 2 Diabetes
1 trial -
Ublituximab
TG THERAPEUTICS, INC.
Multiple Sclerosis (MS) - Relapsing-remitting
1 trial -
Urinary EDC metabolite testing
Marker Therapeutics
Obesity &Amp;Amp;Amp; Overweight
1 trial -
Urinary EDC metabolite testing
Marker Therapeutics
Environmental Exposure
1 trial -
Use baby moisturizers by NeoChine
The First People's Hospital of Lianyungang
Neonatal Jaundice
1 trial -
Use of Mitomycin-C in trabeculectomy
AEON Biopharma
Open-angle Glaucoma
1 trial -
Uteratonic administration
Tarsus Pharmaceuticals
Placenta Abruptio
1 trial -
Venclexta 100 MG Oral Tablet
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
Voglibose tablets
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Heart Disease
1 trial -
Whole peanuts without skins, Peanut butter, or no peanuts (control)
United Therapeutics Europe Ltd
Type 2 Diabetes Mellitus
1 trial -
WonderLab Collagen Tripeptide Drink
Chongqing Precision Biotech Co., Ltd
Skin Laxity
1 trial -
Wonderlab Kids instant probiotics
Chongqing Precision Biotech Co., Ltd
Immunity
1 trial -
Wonderlab Nicotinamide Drink
Chongqing Precision Biotech Co., Ltd
Skin Darken
1 trial -
Xuebi formula
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetic Peripheral Neuropathy
1 trial -
Yinxingmihuan oral solution
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Stable Angina
1 trial -
araboxylan
Sun Yat-sen University
Subjects With Hyperuricemia
1 trial -
bitter melon peptides
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetes
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources